SAFERPeanut Allergy Biomarkers in Oral Food Challenge for Children and Teens
This study aims to observe and assess how children and teens with peanut allergies react to different doses of peanut protein during an oral food challenge.
Data Collection
Nut and Peanut Hypersensitivity+3
+ Food Hypersensitivity
+ Hypersensitivity
Summary
Study start date: April 1, 2026
Actual date on which the first participant was enrolled.This study is focused on understanding how children and teenagers, aged 12 months to 17 years, react to peanuts during an oral food challenge. The aim is to identify specific markers in the blood that can predict allergic reactions. This research is important because it could lead to better ways of diagnosing peanut allergies and predicting severe reactions, which can help improve safety and care for young people with potential peanut allergies. The researchers hope to include over 500 participants to ensure a comprehensive study, with special attention to including enough children who do react and those who do not. Participants will first attend a screening visit to ensure they are eligible for the study and to collect initial blood samples. Following this, they will undergo a controlled peanut oral food challenge, which may occur on the same day or within four weeks after the screening. During this challenge, children will be given measured amounts of peanut protein to see at what point, if any, they show allergic symptoms. Clinical assessments, questionnaires, and additional blood samples will be collected throughout the process to monitor reactions and gather data. Once the challenge and a subsequent safety period are completed, the participant's involvement in the study ends.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.500 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 12 Months to 17 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 10 locations
Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology
Little Rock, United StatesOpen Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology in Google MapsStanford School of Medicine: Sean N. Parker Center for Allergy & Asthma Research
Palo Alto, United StatesNorthwestern University Feinberg School of Medicine: Allergy Division
Chicago, United StatesJohns Hopkins Children's Center: Department of Allergy & Immunology
Baltimore, United States